Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgG Deficiency”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Not applicableStudy completedNCT01166074
What this trial is testing

Retrospective Chart Review of Subcutaneous IgG Use in Infants

Who this might be right for
Primary Immune Deficiency
CSL Behring 27
Not applicableStudy completedNCT01287689
What this trial is testing

Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study

Who this might be right for
Primary Immunodeficiency (PID)Secondary Immunodeficiency (SID)Neurological Autoimmune Disease
Technische Universität Dresden 685
Early research (Phase 1)Study completedNCT00000876
What this trial is testing

Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Large-scale testing (Phase 3)Study completedNCT00168025
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 89
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Early research (Phase 1)Study completedNCT00000675
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04944979
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 30
Not applicableStudy completedNCT05621876
What this trial is testing

Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia

Who this might be right for
Primary Immunodeficiency Diseases
PATH 50
Large-scale testing (Phase 3)Study completedNCT00680446
What this trial is testing

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Who this might be right for
Primary Immune Deficiency
CSL Limited 41
Post-approval studies (Phase 4)Study completedNCT02881437
What this trial is testing

IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

Who this might be right for
Primary Immunodeficiency
University Hospital, Lille 22
Not applicableStudy completedNCT00661401
What this trial is testing

Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin

Who this might be right for
Common Variable ImmunodeficiencyAgammaglobulinemia
Federal University of São Paulo 5
Post-approval studies (Phase 4)Looking for participantsNCT07135427
What this trial is testing

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-AntitrypsinCOPDAntibody Deficiency
University of Alabama at Birmingham 30
Large-scale testing (Phase 3)Study completedNCT00220766
What this trial is testing

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Who this might be right for
Immunologic Deficiency SyndromeAgammaglobulinemiaSevere Combined Immunodeficiency+2 more
Grifols Therapeutics LLC 100
Post-approval studies (Phase 4)WithdrawnNCT03737617
What this trial is testing

Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis

Who this might be right for
BronchiectasisImmunoglobulin Subclass Deficiency
University of Edinburgh
Not applicableUnknownNCT03357978
What this trial is testing

Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia

Who this might be right for
Ataxia Telangiectasia
Johann Wolfgang Goethe University Hospital 30
Not applicableStudy completedNCT04818177
What this trial is testing

Immunoglobulin G Therapy Dose Optimization

Who this might be right for
ObesityImmune Deficiency
Rutgers, The State University of New Jersey 40
Testing effectiveness (Phase 2)Study completedNCT00001145
What this trial is testing

Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome

Who this might be right for
Immunoproliferative Disorder
National Institute of Allergy and Infectious Diseases (NIAID) 5
Next Page